Xencor Stock Earns Relative Strength Rating Upgrade

Group 1 - Taiwan Semiconductor Manufacturing Company (TSMC) reported better-than-expected earnings and provided an optimistic guidance, contributing to a positive opening in the stock market [1] - Xencor (XNCR) stock experienced an upgrade in its Relative Strength (RS) Rating from 62 to 78, indicating improved price performance [1] - Other companies such as Scholar Rock Holding, Ginkgo Bioworks Holdings, and Cytokinetics also received RS Rating upgrades, reflecting a trend of rising stock performance in the market [3] Group 2 - The IBD Relative Strength Rating is a tool that evaluates stock price behavior on a scale from 1 to 99, with higher scores indicating better performance [1] - Dianthus Therapeutics achieved an RS Rating upgrade, highlighting its strong performance in the medical sector [3] - The market is seeing a notable interest in medical stocks, with several companies joining IBD watchlists due to their recent performance [3]